Skip to main content
Quest Diagnostics

Report of the ASFA Apheresis Registry Study on Focal Segmental Glomerulosclerosis

Report of the ASFA Apheresis Registry Study on Focal Segmental Glomerulosclerosis

Authors: Srivaths P, Monis GF, Fernando LP, Hendrickson JE, Raval JS, Jacquot C, Davis K, Wong E, Yamada C

Citation: J Clin Apher. 2025 Aug;40(4):e70041. doi: 10.1002/jca.70041.

Specialties:  Transplant, Hematology, Coagulation

Related content

Publication
Burden and frequency of viral testing of kidney and non-kidney transplant recipients
Test FAQ
Donor Testing
Test FAQ
Kidney Profile
On-Demand Webinar
Rethinking the Basics of Post-transplant Infections
On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.